SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-037212
Filing Date
2018-06-12
Accepted
2018-06-12 16:11:40
Documents
2
Period of Report
2018-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 POA DOCUMENT poa.txt EX-24.3_795978 3000
  Complete submission text file 0001209191-18-037212.txt   5955
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Issuer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 THIRD STREET, FIRST FLOOR CAMBRIDGE MA 02142
Business Address
Hack Andrew A. F. (Reporting) CIK: 0001657434 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38268 | Film No.: 18894553